Without expensive CI would of course be very nice, provided the results are adequate. plx-3397, now owned by Merck, would be the only connection to a BP right? Merck not happy with this I think.
I agree that patient specific combos are where this initially will be headed as a cost effective approach to treatment with the L/Poly ICLC use likely part of SOC and the other more patient specific. Poly ICLC is cheap compared to everything else. Best wishes.